| Literature DB >> 31830027 |
Sébastien Marcombe1, Bénédicte Fustec2, Julien Cattel3, Somesanith Chonephetsarath1, Phoutmany Thammavong1, Nothasin Phommavanh1, Jean-Philippe David3, Vincent Corbel2, Ian W Sutherland4, Jeffrey C Hertz4, Paul T Brey1.
Abstract
BACKGROUND: The yellow fever mosquito Aedes aegypti is the major vector of dengue, yellow fever, Zika, and Chikungunya viruses. Worldwide vector control is largely based on insecticide treatments but, unfortunately, vector control programs are facing operational challenges due to mosquitoes becoming resistant to commonly used insecticides. In Southeast Asia, resistance of Ae. aegypti to chemical insecticides has been documented in several countries but no data regarding insecticide resistance has been reported in Laos. To fill this gap, we assessed the insecticide resistance of 11 Ae. aegypti populations to larvicides and adulticides used in public health operations in the country. We also investigated the underlying molecular mechanisms associated with resistance, including target site mutations and detoxification enzymes putatively involved in metabolic resistance. METHODS ANDEntities:
Year: 2019 PMID: 31830027 PMCID: PMC6932826 DOI: 10.1371/journal.pntd.0007852
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
List of the Aedes aegypti populations collected from the north to the south and their GPS coordinates.
Population abbreviation names are used throughout the text.
| Province | District | Village | Abbreviations | GPS coordinates | |
|---|---|---|---|---|---|
| Xayaboury | Borten | Taling | XBRTL | 17.784729°N | 101.170521°E |
| Luang Prabang | Luang Prabang | Khomkhuang | LPBKKG | 19.902775°N | 102.156213°E |
| Vientiane Capital | Saythany | Oudomphon | VTEODP | 18.125733°N | 102.665011°E |
| Saravane | Lakhonepheng | Lakhonepheng | SRVLKP | 15.485507°N | 105.403469°E |
| Attapeu | Samakheexay | Xaysa-art | ATPXA | 14.484109°N | 106.501415°E |
*VTEIPL strain, collected at the Institut Pasteur du Laos
Fig 1Locations of the mosquito collection sites.
Source: MALVEC Project 2016, Institut Pasteur du Laos—IRD, SavGIS software.
Resistance status of Aedes aegypti larvae (reference and field strains) against temephos, deltamethrin, permethrin, and DDT.
| Insecticide | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| temephos | deltamethrin | permethrin | DDT | |||||||||||||||||||||||||
| Strain | Slope (± se) | LC50 (95% CI) (μg/L) | LC95 (95% CI) (μg/L) | RR50 * | RR95 * | χ2 | p | Slope (± se) | LC50 (95% CI) (μg/L) | LC95 (95% CI) (μg/L) | RR50 * | RR95 * | χ2 | p | Slope (± se) | LC50 (95% CI) (μg/L) | LC95 (95% CI) (μg/L) | RR50 * | RR95 * | χ2 | p | Slope (± se) | LC50 (95% CI) (μg/L) | LC95 (95% CI) (μg/L) | RR50 * | RR95 * | χ2 | p |
| USDA | 4.6 (0.3) | 2.9 (2.7–3.1) | 6.6 (5.8–7.6) | - | - | 3.7 | 0.59 | 1.8 (0.2) | 0.08 (0.07–0.1) | 0.66 (0.43–1.2) | - | - | 0.6 | 0.7 | 10 (0.8) | 1.1 (1.1–1.2) | 1.6 (1.6–1.7) | - | - | 3 | 0.56 | 2.6 (0.2) | 4.6 (4.1–5.1) | 19.6 (16–25.8) | - | - | 7.7 | 0.10 |
| XBLTL | 2.2 (0.14) | 13.5 (12.2–15.2) | 73.8 (57.5–101) | 1.6 | 0.44 | 3.3 (0.3) | 0.6 (0.55–0.66) | 1.9 (1.6–2.4) | 3.9 | 0.3 | 4 (0.3) | 10.3 (9.6–11) | 26.3 (23.2–31.1) | 5.8 | 0.21 | 4.8 (0.6) | 790 (728–891) | 1750 (1402–2519) | 4.1 | 0.39 | ||||||||
| LPBKKG | 4.2 (0.2) | 4.5 (4–5) | 11.1 (10–13.4) | 9.9 | 0.02 | 3.4 (0.2) | 0.57 (0.54–0.6) | 1.75 (1.57–2.01) | 5 | 0 | - | - | - | - | - | - | - | 3.3 (0.5) | 112 (76–139) | 359 (323–418) | 0.2 | 0.88 | ||||||
| LPBTNY | 5.5 (0.3) | 5.6 (5.3–5.9) | 11.7 (10.8–12.9) | 5.5 | 0.14 | 3.4 (0.4) | 0.92 (0.86–1.02) | 2.82 (2.27–3.81) | 3.1 | 0.4 | - | - | - | - | - | - | - | 4.7 (0.4) | 382 (359–404) | 856 (769–985) | 4.8 | 0.3 | ||||||
| LPBTCL | 5.1 (0.3) | 6.7 (6.5–7.1) | 14.1 (12.7–16.2) | 0.3 | 0.96 | 2.7 (0.3) | 0.96 (0.87–1.09) | 3.93 (2.91–6.16) | 0.6 | 1 | 4.2 (0.32) | 9.2 (8.7–9.8) | 22.7 (20–26.4) | 2 | 0.85 | 1.4 (0.2) | 87 (52–118) | 1380 (958–2547) | 3.5 | 0.63 | ||||||||
| VTEODP | 4.2 (0.5) | 7 (6.4–7.8) | 17.2 (13.8–24.4) | 4.5 | 0.10 | 4.8 (0.4) | 1.1 (1–1.2) | 2.26 (1.9–2.8) | 1.9 | 0.4 | 3.6 (0.3) | 13.5 (10.4–19.5) | 38.8 (37.9–123) | 12 | 0.01 | 5.2 (0.4) | 435 (410–457) | 901 (833–995) | 5.7 | 0.34 | ||||||||
| VTEPLM | 4.8 (0.5) | 5.4 (4.9–5.9) | 11.9 (10.6–14) | 0.3 | 0.88 | 3.8 (0.6) | 1.5 (1.2–1.9) | 3.9 (2.7–8) | 1.1 | 0.8 | - | - | - | - | - | - | - | 3.9 (0.5) | 571 (518–641) | 1479 (1185–2076 | 3.1 | 0.21 | ||||||
| VTEDPL | 4.5 (0.3) | 6.4 (5.9–6.9) | 18.8 (15.6–24.7) | 4.5 | 0.21 | 2.8 (0.3) | 0.65 (0.59–0.72) | 2.45 (1.9–3.5) | 5.8 | 0.3 | - | - | - | - | - | - | - | 3.1 (0.3) | 461 (421–503) | 1587 (1310–2074) | 0.9 | 0.82 | ||||||
| VTEIPL | 6.6 (0.5) | 6.6 (6.2–6.9) | 11.6 (10.5–13.5) | 5.3 | 0.07 | 2.6 (0.2) | 1 (0.91–1.11) | 5.2 (3.9–7.5) | 2.6 | 0.6 | 4.8 (0.45) | 16.7 (15.2–19.5) | 36.5 (32–57.7) | 13 | 0.03 | 3.8 (0.3) | 441 (404–476) | 1180 (1034–1403) | 2.0 | 0.58 | ||||||||
| SRVLKP | 2.5 (0.3) | 9.7 (8.3–11.1) | 43.1 (33.4–63.7) | 1.6 | 0.66 | 4.3 (0.3) | 1.4 (1.3–1.6) | 6.8 (5.1–10) | 11 | 0.1 | 5.1 (0.4) | 10.6 (10–11.2) | 22.2 (19.9–25.7) | 3.8 | 0.58 | 3.6 (0.4) | 332 (301–361) | 941 (801–1186) | 6.7 | 0.15 | ||||||||
| SRVKS | 3.8 (0.3) | 8.8 (8.2–9.7) | 24.2 (19.9–31.9) | 1.3 | 0.53 | 3 (0.2) | 0.5 (0.4–0.6) | 1.6 (1.4–1.9) | 8 | 0.2 | - | - | - | - | - | - | - | 3.4 (0.3) | 44 (29–58) | 135 (125–300) | 24.9 | 0.0001 | ||||||
| ATPXA | 2.9 (0.8) | 9.9 (6.9–33) | 36.7 (36.2–61) | 0.5 | 0.78 | 3.7 (0.3) | 0.5 (0.4–0.6) | 1.4 (1.2–1.9) | 9.8 | 0.1 | 3.9 (0.5) | 2.2 (1.5–2.5) | 5.7 (5.1–9.6) | 9.9 | 0.04 | 2.4 (0.2) | 35 (25–47) | 174 (144–334) | 22.9 | 0.0004 |
LC = Lethal concentration, RR = Resistant Ratio, CI = confidence interval. Significant RR are shown in bold.
Fig 2Mortality rates and 95% confidence intervals in WHO tube tests of wild adult Aedes aegypti populations from Laos.
USDA: susceptible reference strain.
Insecticidal activity of temephos against Aedes aegypti larvae (reference strain and field populations) with and without inhibitors.
| Strain | Larvicides | Slope (± se) | LC50 (95% CI) (μg/L) | LC95 (95% CI) (μg/L) | χ2 | p | SR50
| SR95
|
|---|---|---|---|---|---|---|---|---|
| USDA | temephos | 4.6 (0.3) | 2.9 (2.7–3.1) | 6.6 (5.8–7.6) | 3.7 | 0.59 | - | - |
| temephos + DEF | 3.2 (0.2) | 1.3 (0.9–1.7) | 4.2 (3.4–8.1) | 11.9 | 0.0075 | 1.57 | ||
| temephos + DEM | 8.1 (0.8) | 5.3 (5.1–5.6) | 8.5 (7.6–9.8) | 5.7 | 0.057 | |||
| temephos + PBO | 5 (0.4) | 4.3 (3.6–5.2) | 9.1 (8.2–16.3) | 8.7 | 0.034 | |||
| SRVLKP | temephos | 2.5 (0.3) | 9.7 (8.3–11.1) | 43.1 (33.4–63.7) | 1.6 | 0.66 | ||
| temephos + DEF | 3.6 (0.4) | 3.2 (2.9–3.6) | 9.4 (7.5–13) | 0.24 | 0.62 | |||
| temephos + DEM | 5.9 (0.8) | 7.5 (7–8) | 14.1 (12.2–17.9) | 0.006 | 0.94 | |||
| temephos + PBO | 6.2 (0.5) | 7.3 (6.8–7.8) | 13.4 (12–15) | 0.26 | 0.61 | |||
| XBRTL | temephos | 2.2 (0.14) | 13.5 (12.2–15.2) | 73.8 (57.5–101) | 1.6 | 0.44 | ||
| temephos + DEF | 1.8 (0.1) | 3.3 (2.7–3.9) | 24.9 (19.8–33.8) | 8.8 | 0.12 | |||
| temephos + DEM | 5.5 (0.5) | 11 (10.3–11.7) | 21.9 (19.5–25.7) | 6.4 | 0.09 | |||
| temephos + PBO | 4.3 (0.4) | 10.1 (9.4–10.9) | 24.5 (21.3–29.8) | 6.4 | 0.09 | |||
| LPBTCL | temephos | 5.5 (0.4) | 6.7 (6.5–7.1) | 14.1 (12.7–16.2) | 0.31 | 0.95 | - | - |
| temephos + DEF | 3.8 (0.4) | 2.1 (1.9–2.3) | 5.8 (4.9–7.2) | 5.5 | 0.14 | |||
| temephos + DEM | 5.5 (0.8) | 5.2 (4.9–5.6) | 8.7 (7.5–11.5) | 0.026 | 0.87 | |||
| temephos + PBO | 7.4 (1.3) | 5.7 (5.3–6.4) | 11.4 (9.2–16.7) | 0.15 | 0.92 | 1.24 | ||
| VTEIPL | temephos | 6.6 (0.5) | 6.6 (6.2–6.9) | 11.6 (10.5–13.5) | 5.3 | 0.07 | ||
| temephos + DEF | 3.7 (0.3) | 3 (2.7–3.3) | 8.3 (7.1–10.2) | 3.4 | 0.49 | |||
| e | temephos + DEM | 6.5 (0.9) | 5,4 (5.1–5.8) | 9.7 (8.3–12.5) | 1.5 | 0.48 | 1.2 | |
| e | temephos + PBO | 7.6 (0.9) | 5.6 (5.3–6) | 9.2 (8.2–11) | 0.7 | 0.4 | ||
| ATPXR | temephos | 2.9 (0.8) | 9.9 (6.9–33) | 36.7 (36.2–61) | 0.5 | 0.78 | ||
| temephos + DEF | 3.7 (0.3) | 3 (2.7–3.3) | 8.3 (7.1–10.2) | 3.3 | 0.5 | |||
| temephos + DEM | 6.4 (0.8) | 5.4 (5.1–5.8) | 9.7 (8.3–12.5) | 1.5 | 0.48 | |||
| temephos + PBO | 7.6 (0.9) | 5.6 (5.3–6) | 9.2 (8.2–11) | 0.7 | 0.4 |
*LC = Lethal concentration. CI = Confidence Interval. SR = Synergist ratio, Significant SR are shown in bold.
Fig 3Mortality (%) and standard deviation of adult Aedes aegypti after exposure to permethrin (0.25%) and malathion (0.8%) with and without inhibitors (DEF: 8%, DEM: 8%, and PBO: 4%).
Fig 4Activity of detoxification enzymes and 95% Confidence Interval in field caught Aedes aegypti populations in comparison to the susceptible reference strain (USDA): cytochrome P450 monooxygenases (P450s; A), Glutathione-S transferases (GSTs; B), Esterases (α and β-CCEs; C and D). Sample sizes are 47 specimens/population. An asterisk (*) denotes significantly higher levels of detoxifying enzyme compared to the susceptible reference strain USDA.
Genotype distribution and allelic frequency of the V1016G and F1534C kdr mutations.
| V1016G | F1534C | |||||||
|---|---|---|---|---|---|---|---|---|
| POPULATION | SS | RS | RR | F(R) | SS | RS | RR | F(R) |
| 86 | 30 | 2 | 0.14 | 2 | 31 | 85 | 0.85 | |
| 34 | 40 | 10 | 0.36 | 12 | 43 | 32 | 0.62 | |
| 53 | 43 | 12 | 0.31 | 12 | 43 | 53 | 0.69 | |
| 90 | 8 | 0 | 0.04 | 0 | 11 | 87 | 0.94 | |
| 91 | 24 | 1 | 0.11 | 1 | 27 | 88 | 0.88 | |
| 102 | 4 | 2 | 0.04 | 1 | 7 | 100 | 0.96 | |
| 81 | 6 | 18 | 0.20 | 2 | 34 | 69 | 0.82 | |
| 87 | 28 | 2 | 0.14 | 2 | 31 | 84 | 0.85 | |
| 101 | 13 | 1 | 0.07 | 0 | 13 | 102 | 0.94 | |
| 50 | 0 | 0 | 0.00 | 3 | 27 | 20 | 0.67 | |
| 50 | 0 | 0 | 0.00 | 37 | 14 | 0 | 0.14 | |
Fig 5Haplotypes frequencies of V1016G and F1534C kdr mutations in Aedes aegypti populations from Laos.
Fig 6Significant positive correlations identified CNV of detoxification genes and population resistance levels.
Resistance levels are expressed as RR50 for larvae and % survival to WHO insecticide test for adults.